The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
In Vitro Antibacterial Properties of Cefiderocol, a Novel Siderophore Cephalosporin, against Gram-Negative Bacteria
Open accessAbstract
Cefiderocol (CFDC; S-649266), a novel parenteral siderophore cephalosporin conjugated with a catechol moiety, has a characteristic antibacterial spectrum with a potent activity against a broad range of aerobic Gram-negative bacterial species, including carbapenem-resistant strains of Enterobacteriaceae and nonfermenting bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii . Cefiderocol has affinity mainly for penicillin-binding protein 3 (PBP3) of Enterobacteriaceae and nonfermenting bacteria similar to that of ceftazidime. A deficiency of the iron transporter PiuA in P. aeruginosa or both CirA and Fiu in Escherichia coli caused 16-fold increases in cefiderocol MICs, suggesting that these iron transporters contribute to the permeation of cefiderocol across the outer membrane. The deficiency of OmpK35/36 in Klebsiella pneumoniae and the overproduction of efflux pump MexA-MexB-OprM in P. aeruginosa showed no significant impact on the activity of cefiderocol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically
Ferraro, M. J. (2000) · Cited by 16,875
One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products
Datsenko, K. A., & Wanner, B. L. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120163297 · Cited by 14,782
Performance standards for antimicrobial susceptibility testing
Ferraro, M. J. (2001) · Cited by 9,667
Comprehensive transposon mutant library of Pseudomonas aeruginosa
Jacobs, M. A., Alwood, A., Thaipisuttikul, I., Spencer, D., Haugen, E., Ernst, S., Will, O., Kaul, R., Raymond, C., Levy, R., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036282100 · Cited by 1,126
WHO PUBLISHES LIST OF BACTERIA FOR WHICH NEW ANTIBIOTICS ARE URGENTLY NEEDED
City, P. S. M. M. (2017) · Cited by 1,071
Jorgensen, J. H., & Clinical (2006) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,047
Properties of the Penicillin‐Binding Proteins of Escherichia coli K12
SPRATT, B. G. (1977) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1977.tb11258.x · Cited by 631
Jorgensen, J. H., Hindler, J. F., Reller, L. B., & Weinstein, M. P. (2007) · Clinical Infectious Diseases · doi:10.1086/510431 · Cited by 534
Ito, A., Nishikawa, T., Matsumoto, S., Yoshizawa, H., Sato, T., Nakamura, R., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01405-16 · Cited by 352
Self-citationTsai, Y.-K., Fung, C.-P., Lin, J.-C., Chen, J.-H., Chang, F.-Y., Chen, T.-L., & Siu, L. K. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01275-10 · Cited by 344
An improved system for gene replacement and xylE fusion analysis in Pseudomonas aeruginosa
Schweizer, H. P., & Hoang, T. T. (1995) · Gene · doi:10.1016/0378-1119(95)00055-b · Cited by 342
Tängdén, T., & Giske, C. G. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12342 · Cited by 322
Siderophores as drug delivery agents: application of the “Trojan Horse” strategy
Möllmann, U., Heinisch, L., Bauernfeind, A., Köhler, T., & Ankel-Fuchs, D. (2009) · BioMetals · doi:10.1007/s10534-009-9219-2 · Cited by 274
Kohira, N., West, J., Ito, A., Ito-Horiyama, T., Nakamura, R., Sato, T., Rittenhouse, S., Tsuji, M., & Yamano, Y. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01695-15 · Cited by 247
Self-citationPage, M. G. P., Dantier, C., & Desarbre, E. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01525-09 · Cited by 227
Hackel, M. A., Tsuji, M., Yamano, Y., Echols, R., Karlowsky, J. A., & Sahm, D. F. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00093-17 · Cited by 202
Self-citationIto, A., Kohira, N., Bouchillon, S. K., West, J., Rittenhouse, S., Sader, H. S., Rhomberg, P. R., Jones, R. N., Yoshizawa, H., Nakamura, R., et al. (2016) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv402 · Cited by 192
Self-citationStability of Novel Siderophore Cephalosporin S-649266 against Clinically Relevant Carbapenemases
Ito-Horiyama, T., Ishii, Y., Ito, A., Sato, T., Nakamura, R., Fukuhara, N., Tsuji, M., Yamano, Y., Yamaguchi, K., & Tateda, K. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03098-15 · Cited by 187
Self-citationNikaido, H., & Rosenberg, E. Y. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.3.1361-1367.1990 · Cited by 164
Dobias, J., Tendon, V. D., Poirel, L., & Nordmann, P. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3063-z · Cited by 151
Cushman, S. (1989) · Biochemical Education · doi:10.1016/0307-4412(89)90080-0 · Cited by 134
Falagas, M. E., Skalidis, T., Vardakas, K. Z., Legakis, N. J., & on behalf of the Hellenic Cefiderocol Study Group (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx049 · Cited by 122
Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa
Tomaras, A. P., Crandon, J. L., McPherson, C. J., Banevicius, M. A., Finegan, S. M., Irvine, R. L., Brown, M. F., O'Donnell, J. P., & Nicolau, D. P. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00629-13 · Cited by 110
McPherson, C. J., Aschenbrenner, L. M., Lacey, B. M., Fahnoe, K. C., Lemmon, M. M., Finegan, S. M., Tadakamalla, B., O'Donnell, J. P., Mueller, J. P., & Tomaras, A. P. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01345-12 · Cited by 91
Targeting iron assimilation to develop new antibacterials
Foley, T. L., & Simeonov, A. M. (2012) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2012.708335 · Cited by 84
Kim, A., Kutschke, A., Ehmann, D. E., Patey, S. A., Crandon, J. L., Gorseth, E., Miller, A. A., McLaughlin, R. E., Blinn, C. M., Chen, A., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00831-15 · Cited by 82
Sideromycins as Pathogen-Targeted Antibiotics
Wencewicz, T. A., & Miller, M. J. (2017) · Topics in medicinal chemistry · doi:10.1007/7355_2017_19 · Cited by 74
Ghazi, I. M., Monogue, M. L., Tsuji, M., & Nicolau, D. P. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2017.10.008 · Cited by 54
Self-citationHuband, M. D., Ito, A., Tsuji, M., Sader, H. S., Fedler, K. A., & Flamm, R. K. (2017) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2017.03.011 · Cited by 39
Self-citationTomaras, A. P., Crandon, J. L., McPherson, C. J., & Nicolau, D. P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04172-14 · Cited by 32
Kanj, S. S., Whitelaw, A. C., & Dowzicky, M. J. (2013) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2013.10.011 · Cited by 28
Cited by
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Bassetti, M., Echols, R., Matsunaga, Y., Ariyasu, M., Doi, Y., Ferrer, R., Lodise, T. P., Naas, T., Niki, Y., Paterson, D. L., et al. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30796-9 · Cited by 828
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Terreni, M., Taccani, M., & Pregnolato, M. (2021) · Molecules · doi:10.3390/molecules26092671 · Cited by 596
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac268 · Cited by 526
Metadata
- Authors
- Ito, A., Sato, T., Ota, M., Takemura, M., Nishikawa, T., Toba, S., Kohira, N., Miyagawa, S., Ishibashi, N., Matsumoto, S., Nakamura, R., Tsuji, M., & Yamano, Y.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2018-01
- Volume
- 62
- Issue
- 1
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2766395453
- Cited by
- 400
- References
- 31
- FWCI
- 6.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.